Section of Early Detection and Prevention

Prevention and Implementation Group

Key Recent Publications

1. Porras C, Nodora J, Sexton R, Ferreccio C, Jimenez S, Dominguez RL, Cook P, Anderson G, Morgan DR, Baker LH, Greenberg ER, Herrero R. (2013) Epidemiology of Helicobacter pylori infection in six Latin American countries . Cancer Causes Control 24(2):209-15 10.1007/s10552-012-0117-5 – 12 Dec 2012

2. Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, Barletta P, Laudi R, Orellana L. (2015) Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): A population-based cluster randomised trial. Lancet Global Health 3(2):85-94 10.1016/S2214-109X(14)70354-7

3. Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ (2014) International HPV screening working group. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383(9916):524-32 10.1016/S0140-6736(13)62218-7

4. Lowy DR, Herrero R, Hildesheim A. (2015) Primary end-points for future HPV prophylactic vaccine trials: Towards infection and immunobridging. Lancet Oncol. 16(5):226-233 10.1016/S1470-2045(15)70075-6

5. Kreimer AR, Struyf F, Del Rosario Raymundo MR, Hildesheim A, Skinner SR, Wacholder S, Garland SM, Herrero R, David MP, Wheeler CM, for the Costa Rica Vaccine Trial and the PATRICIA study groups (2015) Efficacy of Fewer than Three Doses of a HPV-16/18 AS04 adjuvanted Vaccine: a pooled analysis of data from the Costa Rica Vaccine Trial and the PATRICIA trial.. Lancet Oncol. 16(7):775-86 10.1016/S1470-2045(15)00047-9

6. Villain P, Gonzalez P, Almonte M, Franceschi S, Dillner J, Anttila A, Park JY, De Vuyst H, Herrero R. (2015) European Code against Cancer 4th Edition: Infections and Cancer. Cancer Epidemiol. 1877-7821(15):217-9 10.1016/j.canep.2015.10.006

7. Santesso N, Mustafa RA, Schünemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H, Eckert LO, Forhan SE, Franco EL, Gage JC, Garcia F, Herrero R, Jeronimo J, Lu ER, Luciani S, Quek SC, Sankaranarayanan R, Tsu V, Broutet N (2016) Guideline Support Group. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet. 132(3):252-8 10.1016/j.ijgo.2015.07.038.

8. Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjosé S, Castellsagué X. (2016) Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 4(7):453-63 10.1016/S2214-109X(16)30099-7

9. Rodríguez AC, Ávila C, Herrero R, Hildesheim A, Sherman ME, Burk RD, Morales J, Alfaro M, Guillén D, Trejos ME, Vargas RM, Torres G, Schiffman M. (2017) Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort. . Int J Cancer. 140(8):1926-1934 10.1002/ijc.30614.

10. Ginindza TG, Dlamini X, Almonte M, Herrero R, Jolly PE, Tsoka-Gwegweni JM, Weiderpass E, Broutet N, Sartorius B (2017) Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, Swaziland. PLoS One. 12(1):0170189 10.1371/journal.pone.0170189 23/01/2017

11. Leja M, Park JY, Murillo R, Liepniece-Karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R (2017) Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study. BMJ Open 7(8):016999 10.1136/bmjopen-2017-016999 11/08/2017

Close Reading Mode